Alphavirus replicon particles acting as adjuvants promote CD8+ T cell responses to co-delivered antigen.
about
Vaccines for gonorrhea: can we rise to the challenge?Alphavirus replicon-based enhancement of mucosal and systemic immunity is linked to the innate response generated by primary immunizationAlphavirus-adjuvanted norovirus-like particle vaccines: heterologous, humoral, and mucosal immune responses protect against murine norovirus challengeAdvanced vaccine candidates for Lassa feverChimeric GII.4 norovirus virus-like-particle-based vaccines induce broadly blocking immune responses.Enhancement of protein expression by alphavirus replicons by designing self-replicating subgenomic RNAs.An alphavirus-based adjuvant enhances serum and mucosal antibodies, T cells, and protective immunity to influenza virus in neonatal miceRole of humoral versus cellular responses induced by a protective dengue vaccine candidate.Design of chimeric alphaviruses with a programmed, attenuated, cell type-restricted phenotype.A double-inactivated severe acute respiratory syndrome coronavirus vaccine provides incomplete protection in mice and induces increased eosinophilic proinflammatory pulmonary response upon challengeDNA-Launched Alphavirus Replicons Encoding a Fusion of Mycobacterial Antigens Acr and Ag85B Are Immunogenic and Protective in a Murine Model of TB Infection.Infected dendritic cells are sufficient to mediate the adjuvant activity generated by Venezuelan equine encephalitis virus replicon particlesImmunogenicity and efficacy of alphavirus-derived replicon vaccines for respiratory syncytial virus and human metapneumovirus in nonhuman primatesVaccine Platforms to Control Arenaviral Hemorrhagic FeversVenezuelan equine encephalitis virus replicon particle vaccine protects nonhuman primates from intramuscular and aerosol challenge with ebolavirus.A mucosal adjuvant for the inactivated poliovirus vaccine.Self-replicating alphavirus RNA vaccines.Pseudoinfectious Venezuelan equine encephalitis virus: a new means of alphavirus attenuation.Alphavirus vector-based replicon particles expressing multivalent cross-protective Lassa virus glycoproteins.
P2860
Q21131153-F9513F9D-E641-4181-B8D9-A2F8E13E0FACQ24634730-12CF3B0D-A3B5-430D-A28D-18512EA9805FQ24657762-B67D42D6-EDB8-4091-8A51-85E6DE5318D9Q26823627-6927341B-9D40-414D-A62F-DE74E91FB17DQ33743992-8748D3DC-62C0-4855-83AE-F658EA1E0366Q33972018-679B8B30-42BF-4644-97D4-EEA8D64A0A72Q34059308-86A3AB62-3193-4FC3-97C9-83D843CD039FQ35034240-BE558A60-5B60-4080-AFDA-C79126EC9270Q35076889-301CA050-8404-44B6-82D5-1B0027AC95BAQ35531454-6DCF0D4E-6E37-44D6-8E4C-2EB993608EACQ35758746-9A1F85CB-8289-4A15-BE21-0359C07F974CQ36458651-E7045D96-978A-49B1-8CAB-A7252B83CA73Q36515541-78426DAB-DEA5-4646-BBF2-8EB9791E39D4Q36612929-534992BC-4E23-49AC-9421-B74D3CE2E7EEQ36759944-BBB1830E-44C1-4613-8133-92AE8310BDE7Q37668140-7306079F-DEDA-4B42-B7DB-226DEC6DCCBEQ38255634-12876532-D303-4288-BA98-72DFA83F35C2Q39230468-87896CB0-D5E1-42B2-B976-504ED24CFD81Q47244680-B9EFFD3E-AF62-4B14-A9F9-C8A5B870A628
P2860
Alphavirus replicon particles acting as adjuvants promote CD8+ T cell responses to co-delivered antigen.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Alphavirus replicon particles ...... onses to co-delivered antigen.
@ast
Alphavirus replicon particles ...... onses to co-delivered antigen.
@en
type
label
Alphavirus replicon particles ...... onses to co-delivered antigen.
@ast
Alphavirus replicon particles ...... onses to co-delivered antigen.
@en
prefLabel
Alphavirus replicon particles ...... onses to co-delivered antigen.
@ast
Alphavirus replicon particles ...... onses to co-delivered antigen.
@en
P2093
P2860
P1433
P1476
Alphavirus replicon particles ...... ponses to co-delivered antigen
@en
P2093
Alan C Whitmore
Joseph M Thompson
Robert E Johnston
P2860
P304
P356
10.1016/J.VACCINE.2008.05.046
P407
P577
2008-06-09T00:00:00Z